Evidence map›Paper›PMID 21987263›Full record

ArticleArthritis and rheumatism2012

Interferon-γ regulates discordant mechanisms of uveitis versus joint and axial disease in a murine model resembling spondylarthritis.

Jelena M Kezic, Michael P Davey, Tibor T Glant, James T Rosenbaum, Holly L Rosenzweig

Open access · greenAbstract read
In one paragraph

Article in Arthritis and rheumatism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. The eye in spondyloarthritisSeminars in arthritis and rheumatism · 2019
    Review
  4. Article
  5. Review
  6. The Eyes Have it: A Rheumatologist's View of Uveitis.Arthritis & rheumatology (Hoboken, N.J.) · 2018
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Uveitis in seronegative arthritis.Current rheumatology reports · 2012
    Review
  12. Article
  13. Article
  14. Why HLA-B27? My thirty-year quest: the Friedenwald lecture.Investigative ophthalmology & visual science · 2011
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jelena M KezicOregon Health & Science University, Portland, OR 97239, USA. rosenzwh@ohsu.edu
Michael P Davey
Tibor T Glant
James T Rosenbaum
Holly L Rosenzweig
Oregon Health & Science University · USRush University · US

Funding

Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Kate E Keller · 1995 to 2026
$19.4M
AUTOIMMUNE PROGRESSIVE POLYARTHRITISR01AR040310 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI GLANT, TIBOR T. · 1990 to 2009
$3.1M
Mapping of Arthritis Susceptibility GenesR01AR059356 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI GLANT, TIBOR T. · 2010 to 2014
$2.2M
Understanding uveitis in a multi-system disease model of spondyloarthropathyR01EY021733 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ROSENBAUM, JAMES T, ROSENZWEIG, HOLLY LALLMAN · 2011 to 2014
$1.5M
NOD2 and UveitisR01EY019020 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ROSENZWEIG, HOLLY LALLMAN · 2009 to 2012
$1.5M
Endotoxin-induced Uveitis RevisitedR01EY019604 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ROSENBAUM, JAMES T · 2009 to 2010
$939k
NEI NIH HHS EY-019020NEI NIH HHS EY-019604NEI NIH HHS EY-021733NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY019020NEI NIH HHS R01 EY019604NEI NIH HHS R01 EY021733NIAMS NIH HHS R01 AR040310NIAMS NIH HHS R01 AR059356
6 · The paper itself

Abstract

objectiveThe spondylarthritides (such as ankylosing spondylitis) are multisystem inflammatory diseases that frequently result in uveitis. Despite the common co-occurrence of uveitis with arthritis, there has been no explanation for the susceptibility of the eye to inflammation. Using an innovative intravital videomicroscopic approach, we discovered the coexistence of uveitis with axial and peripheral joint inflammation in mice immunized with cartilage proteoglycan (PG). The aim of this study was to elucidate the characteristics of uveitis and test the impact of interferon-γ (IFNγ) deficiency on the eye versus the joint and spine.

methodsFemale T cell receptor (TCR)-transgenic mice or IFNγ-knockout mice crossed to TCR-transgenic mice were immunized with PG. Uveitis was assessed by intravital videomicroscopy and histology. The clinical and histopathologic severity of arthritis and spondylitis were evaluated. The bone remodeling process within the spine was assessed by whole-body near-infrared imaging. Immunoblotting and immunofluorescence staining were used to examine the expression of PG and ADAMTS-5 and to examine the cellular composition of eyes with uveitis.

resultsPG neoepitopes along with the aggrecanase ADAMTS-5 were present in the eye, as they were the joint. Anterior uveitis developed in response to PG immunization. The cellular infiltrate consisted mainly of neutrophils and eosinophils. Unexpectedly, IFNγ deficiency markedly exacerbated uveitis while ameliorating joint and spine disease, indicating divergent mechanisms that drive diseases in the eye versus the joints and spine.

conclusionThis study provides the first detailed description of a murine disease model in which uveitis coincides with arthritis and spondylitis. Our observations provide a great opportunity for understanding the pathogenesis of a relatively common but poorly understood disease.

Indexed as

ADAM ProteinsAggrecansAnimalsCartilageDisease Models, AnimalEpitopesEyeFemaleInterferon-gammaMiceMice, Inbred BALB CMice, KnockoutSpondylarthritisUveitis, AnteriorADAM ProteinsAggrecansEpitopesInterferon-gamma

Identifiers

PMID21987263
PMCPMC3271189
OpenAlexW2069122480

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.